Xiaoli Wen - Publications

Regulatory effects of leflunomide on gut microecology during IgA nephropathy treatment.

Journal: Renal failure

Published: June 30, 2026

Finerenone for IgA Nephropathy After Renin-Angiotensin System Inhibitors Discontinuation: A Multicentre Retrospective Cohort Study.

Journal: Diabetes, obesity & metabolism

Published: June 22, 2026

Gut microbiota dysbiosis and immune responses: insights from IgA nephropathy and inflammatory bowel disease.

Journal: Frontiers in immunology

Published: May 24, 2026

Correlation of foot process effacement with clinicopathological features and short-term prognosis in IgA nephropathy.

Journal: Annals of medicine

Published: May 20, 2026

Diffuse foot process effacement in IgA nephropathy: MCD-Like versus non-MCD-like phenotypes and response to corticosteroid-based immunosuppression.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: May 04, 2026

Elevated Serum LL37 and Myeloperoxidase-DNA Complexes Predict the Progression of Diabetic Kidney Disease.

Journal: Kidney diseases (Basel, Switzerland)

Published: January 05, 2026

Integrating UHPLC-Q-TOF-MS, Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations to Reveal the Potential Mechanisms of Yiguanjian Decoction in Treating Liver Cancer.

Journal: Chemistry & biodiversity

Published: December 26, 2025

Therapeutic Potential of Salvia miltiorrhiza Active Components in Various Diseases Based on the PI3K/Akt Signaling Pathway.

Journal: Chemistry & biodiversity

Published: October 28, 2025

Neutrophil Percentage to Albumin Ratio is Associated With Diabetic Kidney Disease in Community Cohorts: A More In-Depth Insight Incorporating Machine Learning.

Journal: Nephrology (Carlton, Vic.)

Published: June 30, 2025

Gut microbiota may mediate the causality of statins on diabetic nephropathy: a mediation Mendelian randomization study.

Journal: International urology and nephrology

Published: November 01, 2024

Investigation of Substance Basis and Pharmacodynamics of Qingzao Jiufei Decoction in Lung Cancer Based On Serum Pharmacochemistry and Proteomics.

Journal: Chemistry & biodiversity

Published: October 28, 2024

The Anti-lung Cancer Mechanism of Qingzao Jiufei Decoction was Studied based on Network Pharmacology, Molecular Docking, and Experimental Verification.

Journal: Combinatorial chemistry & high throughput screening

Published: September 10, 2024